Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1979 Aug;34(4):501–507. doi: 10.1136/thx.34.4.501

Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction.

D Pavia, J R Bateman, N F Sheahan, S W Clarke
PMCID: PMC471105  PMID: 159510

Abstract

The effects of (a) regular use for one week and (b) a single dose of a synthetic anticholinergic (ipratropium bromide) on lung mucociliary clearance and as a bronchodilator was ascertained in a controlled, double-blind, cross-over study in 12 patients with reversible airways obstruction (mean increase in FEV after isoprenaline: 17% range 10-50%). Two puffs from a metered dose inhaler of either placebo (propellants only) or drug (40 microgram) were administered four times a day for one week (regular use), and mucociliary clearance was measured, by radioaerosol tracer, at the end of each treatment period and after a control period in which no treatment was given. On the mornings of the measurements after the placebo and drug periods one final dose (single dose) of ipratropium (40 microgram) or placebo was given 2.5 hours before the start of the test. There was no statistically significant difference between the three mean mucociliary clearance curves (control, placebo, and drug) for the group; however, there was a significantly greater penetration towards the periphery of the lung of the tracer in the test after drug administration compared with the other two. This increased penetration was attributed to bronchodilatation caused by the drug. Ipratropium bromide does not appear to impair mucociliary clearance, and it acts an effective bronchodilator.

Full text

PDF
501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Annis P., Landa J., Lichtiger M. Effects of atropine on velocity of tracheal mucus in anesthetized patients. Anesthesiology. 1976 Jan;44(1):74–77. doi: 10.1097/00000542-197601000-00020. [DOI] [PubMed] [Google Scholar]
  2. Booker D. V., Chamberlain A. C., Rundo J., Muir D. C., Thomson M. L. Elimination of 5 mu particles from the human lung. Nature. 1967 Jul 1;215(5096):30–33. doi: 10.1038/215030a0. [DOI] [PubMed] [Google Scholar]
  3. CORSSEN G., ALLEN C. R. Acetylcholine: its significance in controlling ciliary activity of human respiratory epithelium in vitro. J Appl Physiol. 1959 Nov;14:901–904. doi: 10.1152/jappl.1959.14.6.901. [DOI] [PubMed] [Google Scholar]
  4. Cochrane G. M., Webber B. A., Clarke S. W. Effects of sputum on pulmonary function. Br Med J. 1977 Nov 5;2(6096):1181–1183. doi: 10.1136/bmj.2.6096.1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dolovich M. B., Sanchis J., Rossman C., Newhouse M. T. Aerosol penetrance: a sensitive index of peripheral airways obstruction. J Appl Physiol. 1976 Mar;40(3):468–471. doi: 10.1152/jappl.1976.40.3.468. [DOI] [PubMed] [Google Scholar]
  6. Engelhardt A., Klupp H. The pharmacology and toxicology of a new tropane alkaloid derivative. Postgrad Med J. 1975;51(7 Suppl):82–85. [PMC free article] [PubMed] [Google Scholar]
  7. Foster W. M., Bergofsky E. H., Bohning D. E., Lippmann M., Albert R. E. Effect of adrenergic agents and their mode of action on mucociliary clearance in man. J Appl Physiol. 1976 Aug;41(2):146–152. doi: 10.1152/jappl.1976.41.2.146. [DOI] [PubMed] [Google Scholar]
  8. Francis R. A., Thompson M. L., Pavia D., Douglas R. B. Ipratropium bromide: mucociliary clearance rate and airway resistance in normal subjects. Br J Dis Chest. 1977 Jul;71(3):173–178. doi: 10.1016/0007-0971(77)90107-3. [DOI] [PubMed] [Google Scholar]
  9. Goldberg I. S., Lourenço R. V. Deposition of aerosols in pulmonary disease. Arch Intern Med. 1973 Jan;131(1):88–91. [PubMed] [Google Scholar]
  10. Lippmann M., Albert R. E., Peterson H. T., Jr The regional deposition of inhaled aerosols in man. Inhaled Part. 1970;1:105–122. [PubMed] [Google Scholar]
  11. Lippmann M., Albert R. E. The effect of particle size on the regional deposition of inhaled aerosols in the human respiratory tract. Am Ind Hyg Assoc J. 1969 May-Jun;30(3):257–275. doi: 10.1080/00028896909343120. [DOI] [PubMed] [Google Scholar]
  12. Lopez-Vidriero M. T., Costello J., Clark T. J., Das I., Keal E. E., Reid L. Effect of atropine on sputum production. Thorax. 1975 Oct;30(5):543–547. doi: 10.1136/thx.30.5.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Newball H. H., Brahim S. A. Chronic obstructive airway disease in patients with Sjögren's syndrome. Am Rev Respir Dis. 1977 Feb;115(2):295–304. doi: 10.1164/arrd.1977.115.2.295. [DOI] [PubMed] [Google Scholar]
  14. Pavia D., Thomson M. L., Clarke S. W. Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol. Am Rev Respir Dis. 1978 Feb;117(2):199–203. doi: 10.1164/arrd.1978.117.2.199. [DOI] [PubMed] [Google Scholar]
  15. Pavia D., Thomson M. L. Inhibition of mucociliary clearance from the human lung by hyoscine. Lancet. 1971 Feb 27;1(7696):449–450. doi: 10.1016/s0140-6736(71)92432-9. [DOI] [PubMed] [Google Scholar]
  16. Pavia D., Thomson M. L. The fractional deposition of inhaled 2 and 5 mum particles in the alveolar and tracheobronchial regions of the healthy human lung. Ann Occup Hyg. 1976 Nov;19(2):109–114. doi: 10.1093/annhyg/19.2.109. [DOI] [PubMed] [Google Scholar]
  17. Pavia D., Thomson M., Shannon H. S. Aerosol inhalation and depth of deposition in the human lung. The effect of airway obstruction and tidal volume inhaled. Arch Environ Health. 1977 May-Jun;32(3):131–137. doi: 10.1080/00039896.1977.10667269. [DOI] [PubMed] [Google Scholar]
  18. Poppius H., Salorinne Y., Viljanen A. A. Inhalation of a new anticholinergic drug, SCH 1000, in asthma and chronic bronchitis: effect on airway resistance, thoracic gas volume, blood gases and exercise-induced asthma. Bull Physiopathol Respir (Nancy) 1972 May-Jun;8(3):643–653. [PubMed] [Google Scholar]
  19. Thomson M. L., Pavia D. Long-term tobacco smoking and mucociliary clearance from the human lung in health and respiratory impairment. Arch Environ Health. 1973 Feb;26(2):86–89. doi: 10.1080/00039896.1973.10666230. [DOI] [PubMed] [Google Scholar]
  20. Thomson M. L., Pavia D., McNicol M. W. A preliminary study of the effect of guaiphenesin on mucociliary clearance from the human lung. Thorax. 1973 Nov;28(6):742–747. doi: 10.1136/thx.28.6.742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Thomson M. L., Pavia D. Particle penetration and clearance in the human lung. Results in healthy subjects and subjects with chronic bronchitis. Arch Environ Health. 1974 Oct;29(4):214–219. doi: 10.1080/00039896.1974.10666571. [DOI] [PubMed] [Google Scholar]
  22. Thomson M. L., Short M. D. Mucociliary function in health, chronic obstructive airway disease, and asbestosis. J Appl Physiol. 1969 May;26(5):535–539. doi: 10.1152/jappl.1969.26.5.535. [DOI] [PubMed] [Google Scholar]
  23. Yeates D. B., Aspin N., Levison H., Jones M. T., Bryan A. C. Mucociliary tracheal transport rates in man. J Appl Physiol. 1975 Sep;39(3):487–495. doi: 10.1152/jappl.1975.39.3.487. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES